NGL Fine-Chem Peer Comparison

NGL Fine-Chem Ltd. exhibits solid revenue growth and reasonable profitability margins compared to its peers in the pharmaceutical industry. However, it has a high PE ratio, indicating potential overvaluation. Companies like Cipla and Dr. Reddy's Laboratories stand out as strong performers due to their high profitability and lower valuation metrics, making them attractive picks in the sector.

• • NGL Fine-Chem Ltd. shows good growth but high PE ratio (49.44) suggests overvaluation.
• • Cipla and Dr. Reddy's are strong performers with robust returns and lower valuations.
• • Divi's Laboratories shows weak revenue growth over three years, indicating potential concerns.

• • Cipla Ltd.: Strong profitability metrics with a low PE ratio (23.73) and solid revenue growth.
• • Dr. Reddy's Laboratories Ltd.: High ROE and ROA with an attractive PE ratio (15.50), indicating strong performance and value.